![](https://static01.nyt.com/images/2021/10/05/science/02SCI-SPAN-ELDERCARE03/02SCI-SPAN-ELDERCARE03-mediumThreeByTwo440.jpg)
By BY PAULA SPAN from NYT Health https://ift.tt/3mfJxYB
The drug maker claims clinical trials of its new antiviral pill molnupiravir shows the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.